Copyright
©The Author(s) 2025.
World J Gastroenterol. Jan 14, 2025; 31(2): 97239
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.97239
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.97239
Table 1 General statistics, n (%)
| Parameter | Mild group (n = 25) | Moderate group (n = 30) | Severe group (n = 35) | Variance ratio | P value |
| Gender (male:female) | Eleven past two p.m. | Thirteen past five p.m. | Thirteen past ten p.m. | 3.109 | 0.413 |
| Age (years) | 45.17 ± 4.28 | 46.83 ± 4.66 | 45.92 ± 5.18 | 5.226 | 0.385 |
| BMI (kg/m2) | 22.46 ± 1.75 | 23.56 ± 1.49 | 22.85 ± 1.88 | 4.035 | 0.307 |
| Smoker | 8 (32.00) | 10 (33.33) | 12 (34.28) | 2.461 | 0.216 |
| Alcohol consumption | 6 (24.00) | 8 (26.67) | 11 (31.42) | 1.975 | 0.445 |
- Citation: Niu JW, Zhang GC, Ning W, Liu HB, Yang H, Li CF. Clinical effects of phospholipase D2 in attenuating acute pancreatitis. World J Gastroenterol 2025; 31(2): 97239
- URL: https://www.wjgnet.com/1007-9327/full/v31/i2/97239.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i2.97239